✦ LIBER ✦

A unique circulating inhibitor with specificity for coagulation factor X

✍ Scribed by Michael W. Lankiewicz; William R. Bell

Book ID: 115684114
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 392 KB
Volume: 93
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(92)90244-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FGF-19, A NOVEL FIBROBLAST GROWTH FACTOR

FGF-19, A NOVEL FIBROBLAST GROWTH FACTOR WITH UNIQUE SPECIFICITY FOR FGFR4

✍ Ming-Hong Xie; Ilona Holcomb; Bethanne Deuel; Patrick Dowd; Arthur Huang; Alicia 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 390 KB

Evidence for a rebound coagulation pheno

Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris

✍ Herman K. Gold; Frank W. Torres; Harry D. Garabedian; Wendy Werner; Ik-Kyung Jan 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 740 KB

Comparison of a natural heparinoid with

Comparison of a natural heparinoid with sodium and calcium heparin for their effect on the inhibitor of activated factor X

✍ P. M. Mannucci; C. di Santo; F. Franchi 📂 Article 📅 1976 🏛 Springer 🌐 English ⚖ 298 KB

Factor VIII inhibitor following surgery

Factor VIII inhibitor following surgery for epidural hemorrhage in hemophilia: Successful therapy with a concentrate containing factors II, VII, IX, and X

✍ Scott H. Goodnight Jr.; Herbert H. Common; Everett W. Lovrien 📂 Article 📅 1976 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Recurrent inversion with concomitant del

Recurrent inversion with concomitant deletion and insertion events in the coagulation factor VIII gene suggests a new mechanism for X-chromosomal rearrangements causing hemophilia A

✍ Christiane Mühle; Martin Zenker; Nadia Chuzhanova; Holm Schneider 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB

Recurrent int22h-related inversions in the coagulation factor VIII gene (F8) are the most common cause of severe hemophilia A. Such inversions have repeatedly been hypothesized to be associated with concomitant deletions that are responsible for an increased risk of immune responses against therapeu

Non-thrombotic-, non-inhibitor-associate

Non-thrombotic-, non-inhibitor-associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrand’s disease: a systematic review of prospective studies

✍ M. FRANCHINI; M. MAKRIS; E. SANTAGOSTINO; A. COPPOLA; P. M. MANNUCCI 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB